R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

The Parkinson's disease field is increasingly moving toward biologically defined disease frameworks using molecular biomarkers.

R&D

Rare neurology is not defined by a lack of scientific opportunity or capital.

R&D

Lucy Walker is the Head of Medical Operations at the growing medical consultancy LUCENT Biopharma. Find out more in a new 12 Questions With.

R&D

Mike Cooke, CEO of AmacaThera, spoke with pharmaphorum at the LSX World Congress, including about non-opioid pain relief.

R&D

As discovery becomes faster and more accessible, the differentiator shifts downstream.

R&D

A broad mix of senior leadership and scientific and commercial appointments shaped last month’s pharma and biotech hiring activity.